Latest Vivo Capital, LLC Stock Portfolio
Vivo Capital, LLC Performance:
2024 Q3: 17.66%YTD: 23.65%2023: 20.9%
Performance for 2024 Q3 is 17.66%, and YTD is 23.65%, and 2023 is 20.9%.
About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings
Vivo Capital, LLC is a hedge fund based in PALO ALTO, CA. On 28-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.4 Billions. In it's latest 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.2 Billions as of 30 Sep, 2024.
The top stock holdings of Vivo Capital, LLC are SLNO, GERN, HRMY. The fund has invested 26.3% of it's portfolio in SOLENO THERAPEUTICS INC and 10.2% of portfolio in GERON CORP.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), TARSUS PHARMACEUTICALS INC (TARS) and ZAI LAB LTD (ZLAB) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), DELCATH SYSTEMS, INC. (DCTH) and ASTRIA THERAPEUTICS INC (ATXS). Vivo Capital, LLC opened new stock positions in AVADEL PHARMACEUTICALS PLC, CORVUS PHARMACEUTICALS HOLDINGS (CRVS) and TREVI THERAPEUTICS INC (TRVI). The fund showed a lot of confidence in some stocks as they added substantially to UNICYCIVE THERAPEUTICS (UNCY), TERNS PHARMACEUTICALS INC (TERN) and ORIC PHARMACEUTICALS INC (ORIC).
The top stock holdings of Vivo Capital, LLC are SLNO, GERN, HRMY. The fund has invested 26.3% of it's portfolio in SOLENO THERAPEUTICS INC and 10.2% of portfolio in GERON CORP.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), TARSUS PHARMACEUTICALS INC (TARS) and ZAI LAB LTD (ZLAB) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), DELCATH SYSTEMS, INC. (DCTH) and ASTRIA THERAPEUTICS INC (ATXS). Vivo Capital, LLC opened new stock positions in AVADEL PHARMACEUTICALS PLC, CORVUS PHARMACEUTICALS HOLDINGS (CRVS) and TREVI THERAPEUTICS INC (TRVI). The fund showed a lot of confidence in some stocks as they added substantially to UNICYCIVE THERAPEUTICS (UNCY), TERNS PHARMACEUTICALS INC (TERN) and ORIC PHARMACEUTICALS INC (ORIC).
Vivo Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Vivo Capital, LLC made a return of 17.66% in the last quarter. In trailing 12 months, it's portfolio return was 57.27%.
New Buys
| Ticker | $ Bought |
|---|---|
| avadel pharmaceuticals plc | 35,202,100 |
| zenas biopharma inc | 20,020,800 |
| corvus pharmaceuticals holdings | 7,905,580 |
| trevi therapeutics inc | 5,387,100 |
| aligos therapeutics inc | 1,228,670 |
| tenax therapeutics inc | 720,832 |
New stocks bought by Vivo Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| unicycive therapeutics | 28.82 |
| terns pharmaceuticals inc | 11.53 |
| oric pharmaceuticals inc | 0.64 |
Additions to existing portfolio by Vivo Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| cogent biosciences inc | -50.00 |
| delcath systems, inc. | -40.18 |
| astria therapeutics inc | -33.33 |
| dyne therapeutics inc | -31.81 |
| olema pharmaceuticals inc | -19.63 |
| soleno therapeutics inc | -14.01 |
| alx oncology holdings inc | -4.4 |
| allakos inc | -1.07 |
Vivo Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avadel pharmaceuticals plc | -55,847,700 |
| tarsus pharmaceuticals inc | -15,371,600 |
| zai lab ltd | -9,205,660 |
| aadi bioscience inc | -743,975 |
| aligos therapeutics inc | -1,241,460 |
Vivo Capital, LLC got rid off the above stocks
Sector Distribution
Vivo Capital, LLC has about 85.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.7 |
| Others | 14.3 |
Market Cap. Distribution
Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 51.2 |
| MID-CAP | 22 |
| UNALLOCATED | 14.3 |
| MICRO-CAP | 12 |
Stocks belong to which Index?
About 39.2% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 60.8 |
| RUSSELL 2000 | 39.2 |
Vivo Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Vivo Capital, LLC
Vivo Capital, LLC has 43 stocks in it's portfolio. About 77.5% of the portfolio is in top 10 stocks. ALXO proved to be the most loss making stock for the portfolio. SLNO was the most profitable stock for Vivo Capital, LLC last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi bioscience inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABEO | abeona therapeutics, inc. | 0.96 | 1,842,750 | 11,646,200 | unchanged | 0.00 | ||
| ADVM | adverum biotechnologies, inc. | 0.48 | 833,333 | 5,850,000 | unchanged | 0.00 | ||
| ALGS | aligos therapeutics inc | 0.10 | 141,879 | 1,228,670 | new | |||
| ALGS | aligos therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALLK | allakos inc | 0.16 | 2,956,110 | 1,930,930 | reduced | -1.07 | ||
| ALXO | alx oncology holdings inc | 0.61 | 4,034,520 | 7,342,830 | reduced | -4.4 | ||
| ATXS | astria therapeutics inc | 1.42 | 1,552,680 | 17,095,100 | reduced | -33.33 | ||
| AVDL | avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BOLT | bolt therapeutics inc | 0.19 | 3,521,290 | 2,281,800 | unchanged | 0.00 | ||
| CDXS | codexis, inc | 0.10 | 388,144 | 1,195,480 | unchanged | 0.00 | ||
| CELC | celcuity inc | 0.75 | 610,500 | 9,102,560 | unchanged | 0.00 | ||
| CMPS | compass pathway plc | 0.84 | 1,608,000 | 10,130,400 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 0.54 | 3,556,020 | 6,543,080 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 1.00 | 1,122,470 | 12,122,700 | reduced | -50.00 | ||
| CRBP | corbus pharmaceuticals holdings | 0.28 | 166,794 | 3,440,960 | unchanged | 0.00 | ||
| CRVS | corvus pharmaceuticals holdings | 0.65 | 1,497,270 | 7,905,580 | new | |||
| DBVT | dbv technologies sa | 0.08 | 1,354,440 | 948,106 | unchanged | 0.00 | ||
| DCTH | delcath systems, inc. | 0.74 | 997,005 | 9,002,960 | reduced | -40.18 | ||
| DTIL | precision biosciences inc | 0.00 | 4,675 | 41,888 | unchanged | 0.00 | ||